Expression of Fas ligand and Caspase-3 contributes to formation of immune escape in gastric cancer

doi:10.3748/wjg.v9.i7.1415

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3651)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

383

HTML

2946

Figures (1-4)

154

Tables (1-3)

168

Sum=3651

Jul 15, 2003 (publication date) through Jul 28, 2024

Times Cited of This Article

Times Cited (49)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Jul 15, 2003; 9(7): 1415-1420
Published online Jul 15, 2003. doi: 10.3748/wjg.v9.i7.1415

Table 3 Relationship between FasL and Caspase-3 expression in gastric cancer

FasL expression In CC of PF	n	Caspase-3 expression in CC of PF			Caspase-3 expression in ILC of PF
FasL expression In CC of PF	n	-	+~+++	PR(%)	-	+~+++	PR(%)
-	52	39	13	26.92	21	31	65.38
+~+++	61	37	24	37.70	12	49	75.41^a
PR(%)	113	76	37	32.74	33	80	70.80

^aP = 0.016 (χ² = 5.825, Pearson'P = 0.227), vs FasL-negative cases; CC, cancer cells; PF, primary foci; ILC, infiltrating lymphocytes; PR, positive rate.

Citation: Zheng HC, Sun JM, Wei ZL, Yang XF, Zhang YC, Xin Y. Expression of Fas ligand and Caspase-3 contributes to formation of immune escape in gastric cancer. World J Gastroenterol 2003; 9(7): 1415-1420
URL: https://www.wjgnet.com/1007-9327/full/v9/i7/1415.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i7.1415